INFLIXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11412PMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $202.49 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Remicadea | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11423FMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
5 | 5 | 2 | $930.80 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11424GMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $186.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Remicadea | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11432QMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
5 | 5 | 2 | $976.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Renflexisa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12331BMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12340LMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12353EMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12360MMP | ADALIMUMAB adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (PI, CMI) |
3 | 3 | 0 | $2015.19 | $31.60 | $31.60 |
| Available brands | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12367XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12380NMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12381PMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12386XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12393GMP | ADALIMUMAB adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (PI, CMI) |
3 | 3 | 0 | $2015.19 | $31.60 | $31.60 |
| Available brands | |||||||
| Humiraa | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12397LMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12405XMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12446CMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13055DMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL pen device (PI, CMI) |
2 | 2 | 2 | $578.68 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13060JMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL pen device (PI, CMI) |
2 | 2 | 5 | $578.68 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13061KMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL pen device (PI, CMI) |
2 | 2 | 0 | $578.68 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13072BMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL syringe (PI, CMI) |
2 | 2 | 2 | $760.24 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13073CMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL syringe (PI, CMI) |
2 | 2 | 5 | $760.24 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13074DMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL syringe (PI, CMI) |
2 | 2 | 0 | $760.24 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13220TMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13230HMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
USTEKINUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13781HMP | USTEKINUMAB ustekinumab 130 mg/26 mL injection, 26 mL vial (PI, CMI) |
4 | 4 | 0 | $2242.92 | $31.60 | $31.60 |
| Available brands | |||||||
| Stelaraa | |||||||
| Steqeymaa |
USTEKINUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13804MMP | USTEKINUMAB ustekinumab 130 mg/26 mL injection, 26 mL vial (PI, CMI) |
4 | 4 | 0 | $2291.80 | $31.60 | $31.60 |
| Available brands | |||||||
| Stelaraa | |||||||
| Steqeymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 8963RMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 8964TMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 8965WMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 8966XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
INFLIXIMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9654DMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $186.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Remicadea | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9674EMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $202.49 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Remicadea | |||||||
| Renflexisa |
- Legend
- aBrand equivalent a
- MPMedical Practitioner




